Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors Mar 25, 2022
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan Mar 22, 2022
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104 Dec 2, 2021